Cargando…
Oral Vancomycin Prophylaxis for Primary and Secondary Prevention of Clostridioides difficile Infection in Patients Treated with Systemic Antibiotic Therapy: A Systematic Review, Meta-Analysis and Trial Sequential Analysis
Background: Clostridioides difficile infection (CDI) is associated with substantial morbidity and mortality as well as high propensity of recurrence. Systemic antibiotic therapy (SAT) represents the top inciting factor of CDI, both primary and recurrent (rCDI). Among the many strategies aimed to pre...
Autores principales: | Maraolo, Alberto Enrico, Mazzitelli, Maria, Zappulo, Emanuela, Scotto, Riccardo, Granata, Guido, Andini, Roberto, Durante-Mangoni, Emanuele, Petrosillo, Nicola, Gentile, Ivan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8868369/ https://www.ncbi.nlm.nih.gov/pubmed/35203786 http://dx.doi.org/10.3390/antibiotics11020183 |
Ejemplares similares
-
Clostridioides difficile and Enterococci’s Interplay in the Human Gut: Bacterial Alliance or Competition? A Systematic Literature Review
por: Granata, Guido, et al.
Publicado: (2023) -
Utilizing vancomycin as secondary prophylaxis for the prevention of recurrent Clostridioides difficile infection
por: Kristen, Zeitler, et al.
Publicado: (2023) -
2411. One Dose Vancomycin Prophylaxis for In-Hospital Clostridioides difficile - Associated Disease
por: Papic, Neven, et al.
Publicado: (2019) -
The burden of Clostridioides difficile infection in COVID-19 patients: A systematic review and meta-analysis
por: Granata, Guido, et al.
Publicado: (2022) -
Efficacy of oral vancomycin prophylaxis for prevention of Clostridioides difficile infection: a systematic review and meta-analysis
por: Tariq, Raseen, et al.
Publicado: (2021)